$IBO 8-K SEC Filings

Filed On	Filing
09 Oct 2026	8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On November 24, 2025, the Board of Directors (“the Board”), subject to the requisite approval of the shareholders of Impact BioMedical Inc. (the “Company”), approved a proposal to authorize a reverse stock split of the Company’s common s...
17 Sep 2026	8-K: Regulation FD Disclosure Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
15 Sep 2026	8-K: Regulation FD Disclosure CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
04 Mar 2026	8-K: Entry into a Material Definitive Agreement
06 Nov 2025	8-K: Submission of Matters to a Vote of Security Holders
27 Oct 2025	8-K: Other Events
28 Jul 2025	8-K: Entry into a Material Definitive Agreement
23 Jun 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
03 Apr 2025	8-K: Entry into a Material Definitive Agreement
28 Mar 2025	8-K: Entry into a Material Definitive Agreement
13 Mar 2025	8-K: Departure/Election of Directors or Officers; Compensation
29 Jan 2025	8-K: Regulation FD Disclosure
04 Nov 2024	8-K: Regulation FD Disclosure
08 Oct 2024	8-K: Departure/Election of Directors or Officers; Compensation
17 Sep 2024	8-K: Entry into a Material Definitive Agreement; Other Events
07 Jun 2024	8-K: Departure/Election of Directors or Officers; Compensation
22 Jan 2024	8-K: Entry into a Material Definitive Agreement
06 Nov 2023	8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders +2 more

Comments